FDA Inspection 1276112 — Centerline Biomedical Inc
The FDA completed an inspection of Centerline Biomedical Inc on July 2, 2025 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 2, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Cleveland, OH (United States)